Minims Phenylephrine Chlorhydrate Bausch + Lomb Ireland Limited (Phenylephrine Hydrochloride)

Phenylephrine hydrochloride acts as a selective alpha‑1 adrenergic receptor agonist. When applied to the eye, it stimulates receptors on the iris dilator muscle, causing the pupil to enlarge, and on conjunctival vessels, leading to vasoconstriction. This dual action results in mydriasis and reduced redness.

The appropriate dose of Minims Phenylephrine Chlorhydrate is determined by the prescribing eye care professional based on the specific clinical need, patient age, and ocular condition. The prescriber will provide exact instructions on the number of drops and frequency of administration.

Safety data for phenylephrine hydrochloride in pregnancy and lactation are limited. Health care providers generally weigh the potential benefits against any possible risks before prescribing. Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Compared with alternatives such as naphazoline or tetrahydrozoline, phenylephrine offers both mydriatic and vasoconstrictive effects, making it useful for diagnostic dilation as well as redness reduction. Its selectivity for alpha‑1 receptors may result in a slightly different side‑effect profile, particularly regarding intra‑ocular pressure changes.

Store the product at room temperature, ideally below 25 °C. Keep the bottle in its original packaging, protect it from direct sunlight, and ensure the cap is tightly closed to prevent contamination. Do not freeze or expose to extreme temperatures.

The medication is administered topically to the eye. The prescriber will instruct the patient to instill the recommended number of drops into the conjunctival sac, typically avoiding contact with the eyelid or eyelashes. Hands should be washed before and after application.

Serious risks include acute angle‑closure glaucoma, severe allergic reactions such as anaphylaxis, and prolonged mydriasis that may impair vision. Patients with narrow‑angle glaucoma or known hypersensitivity should avoid use, and any sudden visual changes should prompt immediate medical attention.

Individuals with a diagnosis of narrow‑angle or acute angle‑closure glaucoma, known hypersensitivity to phenylephrine or any formulation component, and those advised by their ophthalmologist to avoid mydriatics should not use this product. Consultation with a health professional is essential before use.